Press release
Candidiasis Therapeutics - Clinical Trials & Results and Key Players Analysis SCYNEXIS, Inc., Matinas BioPharma
Download free report sample at: https://www.psmarketresearch.com/market-analysis/candidiasis-therapeutics-pipeline-analysis/report-sample
*Cochleate technology platform for Candidiasis drug development
Matinas Biopharma Holdings, Inc. is using Cochleate technology platform for the development of their drug candidates. The technology platform is a lipid-crystal nano-particle targeted drug delivery system, that offers a drug delivery solution with differentiating and disruptive features including oral availability, multi-organ protection, enhanced safety and targeted delivery to the site of the infection and inflammation along with the ability to effectively penetrate the tissues.
Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=candidiasis-therapeutics-pipeline-analysis
*Ample Designations from the U.S. Food and Drug Administration (USFDA) to the market players manufacturing drugs for Candidiasis
The research found that various companies received many designations from the U.S. Food and Drug Administration (USFDA) for the development of candidiasis therapeutics pipeline. In May 2016, USFDA granted the orphan drug designation to SCY-078 for the treatment of invasive candida infections, including candidemia.
Browse report at: https://www.psmarketresearch.com/market-analysis/candidiasis-therapeutics-pipeline-analysis
Some of the key players developing drugs for the treatment of candidiasis include Seren Pharmaceuticals, Inc., SCYNEXIS, Inc., Matinas Biopharma Holdings, Inc., and others.
About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Candidiasis Therapeutics - Clinical Trials & Results and Key Players Analysis SCYNEXIS, Inc., Matinas BioPharma here
News-ID: 1436841 • Views: …
More Releases from P&S Intelligence
The Rise of Fake Image Detection Solutions: Key Market Insights and Future Trend …
The fake image detection market is projected to expand significantly, from an estimated USD 712.2 million in 2024 to USD 5,811.9 million by 2030, reflecting a robust compound annual growth rate (CAGR) of 41.9% from 2024 to 2030.
Fake images often involve post-production manipulation, where images are altered so subtly that distinguishing the modifications, such as swapped faces or forged signatures, becomes nearly impossible. The proliferation of AI technology and cloud…
Global E-Signature Market Thrives with Rising Security Concerns and Cloud Adopti …
According to the latest market research study published by P&S Intelligence, the e-signature market generated revenue of USD 2,580.3 million in 2023 and is anticipated to achieve a compound annual growth rate (CAGR) of 26.7% from 2024 to 2030, reaching USD 13,407.3 million by 2030. This market expansion can be attributed to increased safety concerns among enterprises, growing government support, and the rising adoption of innovative technologies in emerging countries…
Neurology Had the Major Share in the AI-Based Medical imaging Market
The AI-based medical imaging market will generate USD 11,921.4 million 2030, powering at a robust rate of 30.4% by the end of this decade.
The key factors powering the industry include the increasing occurrence of chronic ailments, growing requirement for medical services for the elderly populace, and increasing research and development expenditure in the healthcare industry.
Furthermore, the incessant progression in imaging tech and the increase in the…
Remote Access Provided by Cloud Category Fuels Call Center AI Market
In 2021, the call center AI market generated sales worth $1,982.9 million, and it is expected to contribute $12,910.6 million in 2030, progressing at a rate of 23.1% from 2021 to 2030, ascribed to the growing up requirements for improved data analytics to manage customer inquiries with the real-time response to improve customer engagement through social media.
In order to pace up the 4th industrial revolution, businesses across various industries…
More Releases for Candidiasis
Candidiasis Epidemiology Insights to 2025
Publisher " Candidiasis - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Candidiasis in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Candidiasis prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with…
Candidiasis Therapeutic and Disease Pipeline Review H1
Summary
Candidiasis is caused by infection with species of the genus Candida, predominantly with Candida albicans. A Candida infection of the skin appears as a clearly defined patch of red, itchy skin, often leaking fluid. Scabs and pustules may be seen around the edge of the rash. It will usually be found in areas such as the groin, the folds of the buttocks, between the breasts, toes, or fingers, and in…
Develop business strategies Of Candidiasis - Pipeline Review, H1 2018
"The Report Candidiasis - Pipeline Review, H1 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
About Candidiasis Market
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Candidiasis - Pipeline Review, H1 2018, provides an overview of the Candidiasis (Infectious Disease) pipeline landscape.
Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1581036
Candidiasis is caused by infection with species of the…
Candidiasis - Pipeline Review, H2 2017
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Candidiasis - Pipeline Review, H2 2017, provides an overview of the Candidiasis (Infectious Disease) pipeline landscape.
Candidiasis is caused by infection with species of the genus Candida, predominantly with Candida albicans. A Candida infection of the skin appears as a clearly defined patch of red, itchy skin, often leaking fluid. Scabs and pustules may be seen around the edge of the…
Candidiasis - Pipeline Review, H2 Pharmaceutical Research Report 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Candidiasis - Pipeline Review, H2 2017”. Candidiasis is caused by infection with species of the genus Candida, predominantly with Candida albicans. A Candida infection of the skin appears as a clearly defined patch of red, itchy skin, often leaking fluid. Scabs and pustules may be seen around the edge of the rash.
Request For…
Candidiasis - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Candidiasis - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Candidiasis - Pipeline Review, H1 2017, provides an overview of the Candidiasis (Infectious Disease) pipeline landscape.
Candidiasis is caused by infection with species of the genus Candida, predominantly with Candida albicans. A Candida infection of the skin…
